col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

220 Results       Page 1

Walter de Gruyter GmbH: Clinical Chemistry and Laboratory Medicine (CCLM)
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―20 Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome Lenka Kujovská Krčmová, Lenka Javorská, Kateřina Matoušová, Petr Šmahel, Mikuláš Skála, Michal Kopecký, et al. (+4)
2 [GO] 2024―Feb―17 Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms: a systematic review of the literature César Fernández-de-las-Peñas, Juan Torres-Macho, Raymart Macasaet, Jacqueline Veronica Velasco, Abbygail Therese Ver, Timothy Hudson David Culasino Carandang, et al. (+4)
3 [GO] 2024―Jan―22 A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test Dan Lane, Rebecca Allsopp, Christopher W. Holmes, Oliver C. Slingsby, Rebekah Jukes-Jones, Paul Bird, et al. (+15)
4 [GO] 2024―Jan―17 Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors Gustavo Cernera, Monica Gelzo, Pietro De Placido, Erica Pietroluongo, Maddalena Raia, Giulia Scalia, et al. (+5)
5 [GO] 2023―Nov―24 SARS-CoV-2 subgenomic RNA: formation process and rapid molecular diagnostic methods Xiao Ge, Huizi Zhou, Fangyuan Shen, Guimao Yang, Yubo Zhang, Xiaoyu Zhang, Heng Li
6 [GO] 2023―Nov―13 Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD+ pathway and SIRT1 activation Caterina Lonati, Georgy Berezhnoy, Nathan Lawler, Reika Masuda, Aditi Kulkarni, Samuele Sala, et al. (+12)
7 [GO] 2023―Nov―09 Unraveling the mystery of blood groups and COVID-19 Connie M. Arthur, Richard D. Cummings, Sean R. Stowell
8 [GO] 2023―Oct―03 Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples Andrea Padoan, Ilaria Talli, Chiara Cosma, Stefania Moz, Giulia Furlan, Filippo Navaglia, et al. (+4)
9 [GO] 2023―Sep―20 ABO blood group-related mechanism of infection of SARS-CoV-2: an overview of systematic reviews Massimo Franchini, Fabrizio Maggi, Daniele Focosi
10 [GO] 2023―Sep―19 Platelet distribution width (PDW) as a significant correlate of COVID-19 infection severity and mortality Daniela Ligi, Chiara Della Franca, Kin Israel Notarte, Nathaniel Goldrich, David Kavteladze, Brandon Michael Henry, Ferdinando Mannello
11 [GO] 2023―Aug―04 The total testing process harmonization: the case study of SARS-CoV-2 serological tests Colombini Alessandra, Divieto Carla, Tomaiuolo Rossella, Mortati Leonardo, Jessica Petiti, Di Resta Chiara, Giuseppe Banfi
12 [GO] 2023―Jun―28 Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment Yuqing Chen, Lei Feng, Yanxi Han, Zihong Zhao, Zhenli Diao, Tao Huang, et al. (+8)
13 [GO] 2023―Jun―14 The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy Filippo Scialò, Gustavo Cernera, Speranza Esposito, Biagio Pinchera, Ivan Gentile, Marina Di Domenico, et al. (+4)
14 [GO] 2023―Jun―07 Neopterin and kynurenine in serum and urine as prognostic biomarkers in hospitalized patients with delta and omicron variant SARS-CoV-2 infection Lenka Kujovská Krčmová, Kateřina Matoušová, Lenka Javorská, Petr Šmahel, Mikuláš Skála, Vladimír Koblížek, et al. (+4)
15 [GO] 2023―Apr―21 Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration Germain Simon, Julien Favresse, Constant Gillot, Mélanie Closset, Émilie Catry, Jean-Michel Dogné, et al. (+3)
16 [GO] 2023―Apr―11 Symposium 2 - COVID-19 diagnosis, therapy and outcome
17 [GO] 2023―Apr―11 COVID-19
18 [GO] 2023―Apr―11 EQALM Symposium - Insights into SARS-CoV-2 associated analytics that only EQA schemes can provide
19 [GO] 2023―Apr―10 C-reactive protein and clinical outcome in COVID-19 patients: the importance of harmonized measurements Elena Aloisio, Giulia Colombo, Alberto Dolci, Mauro Panteghini
20 [GO] 2023―Mar―31 Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing Constant Gillot, Jean-Louis Bayart, Mélanie Closset, Julien Cabo, Vincent Maloteau, Jean-Michel Dogné, et al. (+2)
21 [GO] 2023―Mar―27 SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections Selena Mimmi, Anna Maria Zimbo, Salvatore Rotundo, Erika Cione, Nancy Nisticò, Annamaria Aloisio, et al. (+14)
22 [GO] 2023―Mar―23 SARS-CoV-2 specific T-cell humoral response assessment after COVID-19 vaccination using a rapid direct real-time PCR amplification Chiara Cosma, Luisa Galla, Andrea Padoan, Giulia Furlan, Lucio Marchioro, Martina Zaninotto, et al. (+2)
23 [GO] 2023―Mar―22 Efficiency evaluation of a SARS-CoV-2 diagnostic strategy combining high throughput quantitative antigen immunoassay and real time PCR Luca Bernasconi, Peter Neyer, Michael Oberle, Bettina Schmid, Eileen Martin, Hans Fankhauser, et al. (+2)
24 [GO] 2023―Mar―08 Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay Laura Pighi, Brandon M. Henry, Simone De Nitto, Gianluca Gianfilippi, Gian Luca Salvagno, Mario Plebani, Giuseppe Lippi
25 [GO] 2023―Feb―27 Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing Laura Pighi, Brandon M. Henry, Camilla Mattiuzzi, Simone De Nitto, Gian Luca Salvagno, Giuseppe Lippi
26 [GO] 2023―Feb―17 Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay Philip M. Hemken, Eitan Israeli, Russell Taylor, Chris Jacobson, Maria Datwyler, Rene Geissler, et al. (+31)
27 [GO] 2023―Jan―20 Evaluation of a high-sensitivity SARS-CoV-2 antigen test on the fully automated light-initiated chemiluminescent immunoassay platform Minghang Yu, Danying Chen, Xiaomeng Tang, Yuanyuan Zhang, Pu Liang, Yang Xiong, et al. (+6)
28 [GO] 2023―Jan―12 Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis Giuseppe Lippi, Brandon M. Henry, Mario Plebani
29 [GO] 2023―Jan―12 Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays Giuseppe Lippi, Brandon M. Henry, Mario Plebani
30 [GO] 2023―Jan―11 Stability of SARS-CoV-2 respiratory samples in non-freezing condition: importance for tropical countries under heavy diagnostic demand Bruno Duarte Sabino, Fábio de Oliveira Martinez Alonso, Ana Claudia Dantas Machado, Amadeu Cardoso Junior, Marianna Tavares Venceslau, Fabiana Batalha Knackfuss, Rafael Brandão Varella
31 [GO] 2023―Jan―10 Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis Daniela Ligi, Bruna Lo Sasso, Brandon M. Henry, Marcello Ciaccio, Giuseppe Lippi, Mario Plebani, Ferdinando Mannello
32 [GO] 2022―Dec―14 A panhaemocytometric approach to COVID-19: the importance of cell population data on Sysmex XN-series analysers in severe disease James V. Harte, Caoimhe Ní Choileáin, Conor Grieve, Carmel Hooton, Vitaliy Mykytiv
33 [GO] 2022―Dec―08 Application of ultrasensitive assay for SARS-CoV-2 antigen in nasopharynx in the management of COVID-19 patients with comorbidities during the peak of 2022 Shanghai epidemics in a tertiary hospital Di Wang, Hailong Lu, Yaju Li, Jiazhen Shen, Guangjie Jiang, Jin Xiang, et al. (+2)
34 [GO] 2022―Dec―07 Evaluation of ichroma™ COVID-19 interferon gamma release assay for detection of vaccine-induced immunity in healthcare workers Yong Kwan Lim, Oh Joo Kweon, Yoojeong Choi, Tae-Hyoung Kim, Mi-Kyung Lee
35 [GO] 2022―Dec―06 Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care setting Louis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, An Boel, Lien Cattoir, Kristien Van Vaerenbergh, et al. (+4)
36 [GO] 2022―Nov―23 Clinical Chemistry and Laboratory Medicine celebrates 60 years - narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2 Julien Favresse, Jonathan Douxfils, Brandon Henry, Giuseppe Lippi, Mario Plebani
37 [GO] 2022―Nov―21 The impact of COVID-19 on citations of laboratory medicine journals Giuseppe Lippi
38 [GO] 2022―Nov―17 Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use Jenny Hällqvist, Dan Lane, Andrew Shapanis, Kayleigh Davis, Wendy E. Heywood, Ivan Doykov, et al. (+31)
39 [GO] 2022―Nov―11 Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019 Timothy Tiutan, Joseph S. Wallins, Samantha Brown, Mithat Gonen, Deborah Korenstein
40 [GO] 2022―Nov―07 An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) Giuseppe Lippi, Brandon M. Henry, Mario Plebani
41 [GO] 2022―Nov―03 Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies Tobias Niedrist, Lisa Kriegl, Christoph J Zurl, Felix Schmidt, Nicole Perkmann-Nagele, Patrick Mucher, et al. (+13)
42 [GO] 2022―Oct―31 Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept Gian Luca Salvagno, Brandon M. Henry, Giulio Bongiovanni, Simone De Nitto, Laura Pighi, Giuseppe Lippi
43 [GO] 2022―Oct―25 Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots Luisa Galla, Chiara Cosma, Michela Bertan, Sara Altinier, Martina Zaninotto, Daniela Basso, et al. (+3)
44 [GO] 2022―Oct―25 New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance Ada Aita, Filippo Navaglia, Stefania Moz, Nicole Contran, Francesco Barbaro, Anna Maria Cattelan, et al. (+5)
45 [GO] 2022―Oct―17 Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV2 mRNA or vector vaccine Lorin Loacker, Janine Kimpel, Zoltán Bánki, Christoph Q. Schmidt, Andrea Griesmacher, Markus Anliker
46 [GO] 2022―Sep―17 Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service Francesca Di Gaudio, Giuseppina Brunacci, Flavia Contino, Alessia Gallo, Fabio Centineo
47 [GO] 2022―Jul―18 What is the impact of circulating histones in COVID-19: a systematic review Daniela Ligi, Rosaria Vincenza Giglio, Brandon M. Henry, Giuseppe Lippi, Marcello Ciaccio, Mario Plebani, Ferdinando Mannello
48 [GO] 2022―Jul―14 D-dimer: old dogmas, new (COVID-19) tricks Giuseppe Lippi, François Mullier, Emmanuel J. Favaloro
49 [GO] 2022―Jul―13 Measurement of anti SARS-CoV-2 RBD IgG in saliva: validation of a highly sensitive assay and effects of the sampling collection method and correction by protein Silvia Martínez-Subiela, Lorena Franco-Martínez, Camila P. Rubio, Alberto Muñoz-Prieto, Alberto Torres-Cantero, Fernando Tecles, et al. (+3)
50 [GO] 2022―Jun―24 Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2 Rossella Tomaiuolo, Umberto Restelli, Francesco Cosimo Faggiano, Chiara Di Resta, Sami Al Bitar Nehme, Francesco Giuliani, et al. (+4)
51 [GO] 2022―Jun―24 Presepsin levels in neonatal cord blood are not influenced by maternal SARS-CoV-2 infection Francesca Priolo, Simona Fattore, Marta Tedesco, Domenico Umberto De Rose, Roberto Chioma, Alessandro Perri, et al. (+6)
52 [GO] 2022―Jun―14 Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay Sebastian Hörber, Christoph Drees, Tina Ganzenmueller, Kristina Schmauder, Silke Peter, Dirk Biskup, Andreas Peter
53 [GO] 2022―May―23 Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples Christoph Buchta, Jeremy V. Camp, Jovana Jovanovic, Elisabeth Puchhammer-Stöckl, Robert Strassl, Mathias M. Müller, et al. (+3)
54 [GO] 2022―May―05 How is test laboratory data used and characterised by machine learning models? A systematic review of diagnostic and prognostic models developed for COVID-19 patients using only laboratory data Anna Carobene, Frida Milella, Lorenzo Famiglini, Federico Cabitza
55 [GO] 2022―May―03 Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis Arite Bigalke, Charles Neu, Ricardo Esper Treml, Sina M. Coldewey, Michael Kiehntopf
56 [GO] 2022―Apr―30 COVID-19 related mortality and religious denomination vs. genetics Joris R. Delanghe, Marijn M. Speeckaert, Marc L. De Buyzere
57 [GO] 2022―Apr―27 Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens Antigona Ulndreaj, Mingyue Wang, Salvia Misaghian, Louis Paone, George B. Sigal, Martin Stengelin, et al. (+8)
58 [GO] 2022―Apr―27 A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers Andrea Padoan, Chiara Cosma, Foscarina della Rocca, Francesco Barbaro, Claudia Santarossa, Luigi Dall’Olmo, et al. (+5)
59 [GO] 2022―Apr―27 Artificial intelligence at the time of COVID-19: who does the lion’s share? Davide Negrini, Elisa Danese, Brandon M. Henry, Giuseppe Lippi, Martina Montagnana
60 [GO] 2022―Apr―22 Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group Giuseppe Lippi, Julien Favresse, Michael M. Gromiha, Jeffrey A. SoRelle, Mario Plebani, Brandon M. Henry
61 [GO] 2022―Mar―14 Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay Giuseppe Lippi, Brandon M. Henry, Martina Montagnana, Mario Plebani
62 [GO] 2022―Mar―12 Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold Sander De Bruyne, Stijn Van Landeghem, Alexander Schauwvlieghe, Lucien Noens
63 [GO] 2022―Mar―08 Identification of contagious SARS-CoV-2 infected individuals by Roche’s Rapid Antigen Test Harald H. Kessler, Florian Prüller, Melina Hardt, Evelyn Stelzl, Esther Föderl-Höbenreich, Sabine Pailer, et al. (+4)
64 [GO] 2022―Feb―26 Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry Felix Wachter, Adrian P. Regensburger, Ferdinand Knieling, Alexandra L. Wagner, David Simon, André Hoerning, et al. (+4)
65 [GO] 2022―Feb―16 Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection Annie Ren, Dorsa Sohaei, Antigona Ulndreaj, Oscar D. Pons-Belda, Amaia Fernandez-Uriarte, Ioannis Zacharioudakis, et al. (+14)
66 [GO] 2022―Feb―03 Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department Eloísa Urrechaga, Cristina Ponga, Mónica Fernández, Pedro Pablo España, Rana Zeeshan Haider, Urko Aguirre
67 [GO] 2022―Feb―03 Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis Giuseppe Lippi, Brandon M. Henry, Khosrow Adeli
68 [GO] 2022―Jan―28 A rapid semi-quantitative test for determination of SARS-CoV-2 antibody levels Francesco Broccolo, Silvia Fabris, Massimo Ciccozzi, Mario Plebani
69 [GO] 2022―Jan―18 Hyris bCUBE SARS-CoV-2 rapid molecular saliva testing: a POCT innovation on its way Andrea Padoan, Chiara Cosma, Ada Aita, Filippo Navaglia, Daniela Basso, Gianfranco Giannella, Mario Plebani
70 [GO] 2022―Jan―14 Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role? Francesco Broccolo
71 [GO] 2022―Jan―10 Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment Julien Favresse, Jean-Louis Bayart, Clara David, Marie Didembourg, Constant Gillot, Jean-Michel Dogné, Jonathan Douxfils
72 [GO] 2021―Dec―15 Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays Andrea Padoan, Chiara Cosma, Francesco Bonfante, Foscarina della Rocca, Francesco Barbaro, Claudia Santarossa, et al. (+7)
73 [GO] 2021―Dec―02 Blood lactate concentration in COVID-19: a systematic literature review Giovanni Carpenè, Diletta Onorato, Riccardo Nocini, Gianmarco Fortunato, John G. Rizk, Brandon M. Henry, Giuseppe Lippi
74 [GO] 2021―Dec―02 Molecular detection of SARS-CoV-2 eta VOI in Northern Italy: a case report Francesco Broccolo, Marta Giovanetti, Alessio Colombo, Nicola Perrelli, Adelaide Bussini, Silvia Cavalli, et al. (+2)
75 [GO] 2021―Nov―16 The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, Sara Lococo, Beatrice Molena, Antonella Cecchetto, et al. (+4)
76 [GO] 2021―Nov―09 Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection Christoph Buchta, Jeremy V. Camp, Jovana Jovanovic, Ulla Radler, Bernhard Benka, Elisabeth Puchhammer-Stöckl, et al. (+4)
77 [GO] 2021―Oct―29 Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT) Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi
78 [GO] 2021―Oct―23 Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value Simone Caruso, Elena Aloisio, Alberto Dolci, Mauro Panteghini
79 [GO] 2021―Oct―22 Value of hypocalcemia and thromboinflammatory biomarkers for prediction of COVID-19 severity during the second wave: were all the waves the same? Luis García de Guadiana-Romualdo, Verónica Ramos-Arenas, María Dolores Rodríguez Mulero, Marta Hernández Olivo, Valerio Campos-Rodríguez, María Galindo Martínez, et al. (+4)
80 [GO] 2021―Oct―14 ACE polymorphism is a determinant for COVID-19 mortality in the post-vaccination era Joris R. Delanghe, Marijn M. Speeckaert, Marc L. De Buyzere
81 [GO] 2021―Oct―11 Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign Davide Ferrari, Alessandra Mangia, Maria Sestina Spanò, Lucia Zaffarano, Marco Viganò, Chiara Di Resta, et al. (+3)
82 [GO] 2021―Sep―08 Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role? Giuseppe Lippi, Brandon M. Henry, Mario Plebani
83 [GO] 2021―Sep―07 Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine Silvia Meschi, Giulia Matusali, Francesca Colavita, Daniele Lapa, Licia Bordi, Vincenzo Puro, et al. (+4)
84 [GO] 2021―Sep―02 Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma Massimo Franchini, Carlo Mengoli, Beatrice Caruso, Roberto Petilino, Alessia Ballotari, Claudia Glingani
85 [GO] 2021―Sep―02 Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon M. Henry
86 [GO] 2021―Aug―29 Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19 Claus Lohman Brasen, Henry Christensen, Dorte A. Olsen, Søren Kahns, Rikke F. Andersen, Jeppe B. Madsen, et al. (+7)
87 [GO] 2021―Aug―13 Alternative detection of SARS-CoV-2 RNA by a new assay based on mass spectrometry Evelyn Stelzl, Harald H. Kessler, Hans G. Mustafa, Maria E. Mustafa, Brigitte I. Santner, Josef Seier, et al. (+2)
88 [GO] 2021―Aug―11 Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis Michael Llamas, Maria Luisa Garo, Luca Giovanella
89 [GO] 2021―Aug―04 Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme Laura Sciacovelli, Andrea Padoan, Sandra Secchiero, Mario Plebani
90 [GO] 2021―Jul―31 Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs Cédric Hartard, Sibel Berger, Thomas Josse, Evelyne Schvoerer, Hélène Jeulin
91 [GO] 2021―Jul―31 Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows Michele Mussap, Vassilios Fanos
92 [GO] 2021―Jul―10 Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of “non-thyroidal illness syndrome”? Stelios F. Assimakopoulos, Georgios K. Markantes, Dimitris Papageorgiou, Irene Mamali, Kostas B. Markou, Markos Marangos, Marina A. Michalaki
93 [GO] 2021―Jun―29 The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis Tiffany Pascreau, Marie-Christine Ballester, Patrick Van Dreden, Sara Zia-Chahabi, Benjamin Zuber, Jad Choucair, et al. (+3)
94 [GO] 2021―Jun―29 SARS-CoV-2 antibody assay after vaccination: one size does not fit all Mario Plebani, Chiara Cosma, Andrea Padoan
95 [GO] 2021―Jun―29 The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria Christoph Buchta, Jeremy V. Camp, Jovana Jovanovic, Peter Chiba, Elisabeth Puchhammer-Stöckl, Maximilian Mayerhofer, et al. (+12)
96 [GO] 2021―Jun―23 Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay Gian Luca Salvagno, Brandon M. Henry, Laura Pighi, Simone De Nitto, Gian Luca Gianfilippi, Giuseppe Lippi
97 [GO] 2021―Jun―18 Does COVID-19 alter the oxyhemoglobin dissociation curve? - An observational cohort study using a mixed-effect modelling Mikael Laredo, Emmanuel Curis, Elisabeth Masson-Fron, Sebastian Voicu, Bruno Mégarbane
98 [GO] 2021―Jun―12 Ageing, ACE2 deficiency and bad outcome in COVID-19 Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
99 [GO] 2021―Jun―11 Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro
100 [GO] 2021―May―20 Is COVID-19 a hyperferritinemic syndrome in children? Antonietta Giannattasio, Carolina D’Anna, Stefania Muzzica, Angela Mauro, Margherita Rosa, Francesca Angrisani, et al. (+3)
101 [GO] 2021―May―14 Role of ACE2 polymorphism in COVID-19: impact of age Sadra Mohaghegh, Parisa Motie, Saeed Reza Motamedian
102 [GO] 2021―Apr―28 Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection Lorena Franco-Martínez, Fernando Tecles, Alberto Torres-Cantero, Enrique Bernal, Indra San Lázaro, María José Alcaraz, et al. (+7)
103 [GO] 2021―Apr―28 IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals Mary Kathryn Bohn, Giuseppe Lippi, Andrea R. Horvath, Rajiv Erasmus, Matthias Grimmler, Maurizio Gramegna, et al. (+11)
104 [GO] 2021―Apr―14 Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers Andrea Padoan, Francesco Bonfante, Chiara Cosma, Costanza Di Chiara, Laura Sciacovelli, Matteo Pagliari, et al. (+6)
105 [GO] 2021―Apr―10 Laboratory medicine in the COVID-19 era: six lessons for the future Mario Plebani
106 [GO] 2021―Apr―10 Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series Elisa Danese, Martina Montagnana, Gian Luca Salvagno, Denise Peserico, Laura Pighi, Simone De Nitto, et al. (+3)
107 [GO] 2021―Apr―10 Stability of SARS-CoV-2 RNA in FTA card spot-prep samples derived from nasopharyngeal swabs Gernot Kriegshäuser, Dietmar Enko, Luftar Reçi, Christina Maria Leb, Peter Panhofer
108 [GO] 2021―Apr―10 Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, et al. (+14)
109 [GO] 2021―Apr―07 COVID-19: which lessons have we learned? Giuseppe Banfi, Giuseppe Lippi
110 [GO] 2021―Apr―07 Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups Giulia Menchinelli, Licia Bordi, Flora Marzia Liotti, Ivana Palucci, Maria Rosaria Capobianchi, Giuseppe Sberna, et al. (+7)
111 [GO] 2021―Mar―26 Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients Giovanni Ponti, Laura Roli, Gabriella Oliva, Marco Manfredini, Tommaso Trenti, Shaniko Kaleci, et al. (+13)
112 [GO] 2021―Mar―20 Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data” Remy J. H. Martens, Math P. G. Leers
113 [GO] 2021―Mar―17 Assay requirements for COVID-19 testing: serology vs. rapid antigen tests Ioannis Prassas, Clare Fiala, Eleftherios P. Diamandis
114 [GO] 2021―Mar―15 Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2 Simon Michaelis, Angelika Pichler, Ingeborg Stelzer, Christoph Tinchon, Dietmar Enko
115 [GO] 2021―Mar―13 A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers James V. Harte, Vitaliy Mykytiv
116 [GO] 2021―Mar―13 Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies Fabrizio Bonelli, Frank A. Blocki, Tina Bunnell, Edward Chu, Arriel De La O, David G. Grenache, et al. (+10)
117 [GO] 2021―Mar―06 Protease-antiprotease imbalance in patients with severe COVID-19 Farid Zerimech, Merce Jourdain, Brigitte Onraed, Marion Bouchecareilh, Boualem Sendid, Alain Duhamel, et al. (+2)
118 [GO] 2021―Mar―06 Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR) Santiago J. Ballaz, Mary Pulgar-Sánchez, Kevin Chamorro, Esteban Fernández-Moreira, Hégira Ramírez, Francisco X. Mora, Martha Fors
119 [GO] 2021―Mar―04 25-Hydroxyvitamin D concentrations in COVID-19 patients hospitalized in intensive care unit during the first wave and the second wave of the pandemic Antonin Saldmann, Annabelle Stoclin, Sophie Rym Hamada, Bernard Cholley, Pascal Houillier, Stéphanie Baron, et al. (+6)
120 [GO] 2021―Feb―28 Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak Mariarosa Carta, Luciana Bragagnolo, Andrea Tramarin, Anna Cappelletti, Elena Barzon, Lauretta Forner, et al. (+9)
121 [GO] 2021―Feb―20 Soluble fms-like tyrosine kinase-1: a potential early predictor of respiratory failure in COVID-19 patients José L. Eguiburu-Jaime, Aitor Delmiro, Antonio Lalueza, Pedro L. Valenzuela, José M. Aguado, Carlos Lumbreras, et al. (+4)
122 [GO] 2021―Feb―20 A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity Marc Vasse, Benjamin Zuber, Laurie Goubeau, Marie-Christine Ballester, Mathilde Roumier, Frédérique Delcominette, et al. (+6)
123 [GO] 2021―Feb―14 “Stay home stay safe?” Systemic inflammation in subjects undergoing routine hematology tests during the lockdown period of COVID-19 Francesco Tona, Mario Plebani, Dario Gregori, Giovanni Carretta, Giulia Lorenzoni, Daniele Donato, Sabino Iliceto
124 [GO] 2021―Feb―05 Thrombin generation in patients with COVID-19 with and without thromboprophylaxis Elena Campello, Cristiana Bulato, Luca Spiezia, Annalisa Boscolo, Francesco Poletto, Marco Cola, et al. (+8)
125 [GO] 2021―Jan―23 Prevention and control of COVID-19 in the penitentiary of Florence Mirco Capacci, Maria Infantino, Valentina Grossi, Barbara Lari, Sergio Fabbri, Alessio Bellucci, et al. (+10)
126 [GO] 2021―Jan―23 Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome Stephen W. Smith, Ashley M. Strobel, Amy K. Saenger, Fred S. Apple
127 [GO] 2021―Jan―23 Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients Laurence Orchard, Matthew Baldry, Myra Nasim-Mohi, Chantelle Monck, Kordo Saeed, Michael P. W. Grocott, et al. (+2)
128 [GO] 2021―Jan―23 Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria Margot Egger, Christian Bundschuh, Kurt Wiesinger, Elisabeth Bräutigam, Thomas Berger, Martin Clodi, Benjamin Dieplinger
129 [GO] 2021―Jan―23 Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, et al. (+11)
130 [GO] 2021―Jan―23 Next-generation sequencing and RT-PCR to identify a 32-day SARS-CoV-2 carrier Lingjie Song, Guibao Xiao, Ruixiang Tang, Xianqin Zhang, Zhan Gao, Shixia Sun, et al. (+6)
131 [GO] 2021―Jan―23 Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays Mary Kathryn Bohn, Alexandra Hall, Siobhan Wilson, Jennifer Taher, Lusia Sepiashvili, Khosrow Adeli
132 [GO] 2021―Jan―23 Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination Giuseppe Lippi, Laura Sciacovelli, Tommaso Trenti, Mario Plebani, _ _
133 [GO] 2021―Jan―23 Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death Nicasio Mancini, Nicola Clementi, Roberto Ferrarese, Alessandro Ambrosi, Marco Tonelli, Alberto Zangrillo, et al. (+2)
134 [GO] 2021―Jan―23 Response to: towards the rational utilization of SARS-CoV-2 serological tests in clinical practice Samuel D. Brown, Kate A. Ottaway, Gary Weaving, Kate E. Shipman
135 [GO] 2021―Jan―23 Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach Ezgi Cibali, Jürgen J. Wenzel, Rudi Gruber, Andreas Ambrosch
136 [GO] 2021―Jan―13 The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study Claudia Gregoriano, Daniel Koch, Alexander Kutz, Sebastian Haubitz, Anna Conen, Luca Bernasconi, et al. (+4)
137 [GO] 2020―Dec―22 Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients Julien Favresse, Marc Elsen, Christine Eucher, Kim Laffineur, Sandrine Van Eeckhoudt, Jean-Baptiste Nicolas, et al. (+3)
138 [GO] 2020―Dec―22 Hemocytometric characteristics of COVID-19 patients with and without cytokine Storm syndrome on the Sysmex XN-10 hematology analyzer Remy J. H. Martens, Arjan J. van Adrichem, Nadine J. A. Mattheij, Calvin G. Brouwer, Daan J. L. van Twist, Jasper J. C. R. Broerse, et al. (+6)
139 [GO] 2020―Dec―22 An original multiplex method to assess five different SARS-CoV-2 antibodies Julien Favresse, Jonathan Brauner, Nicolas Bodart, Alain Vigneron, Sandrine Roisin, Sabrina Melchionda, et al. (+2)
140 [GO] 2020―Dec―22 Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR Christoph Buchta, Irene Görzer, Peter Chiba, Jeremy V. Camp, Heidemarie Holzmann, Elisabeth Puchhammer-Stöckl, et al. (+3)
141 [GO] 2020―Dec―14 Cytokine “storm”, cytokine “breeze”, or both in COVID-19? Giuseppe Lippi, Mario Plebani
142 [GO] 2020―Dec―14 SARS-CoV-2 serologic tests: do not forget the good laboratory practice Elena Aloisio, Felicia Stefania Falvella, Assunta Carnevale, Mauro Panteghini
143 [GO] 2020―Nov―30 The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19) Brandon Michael Henry, Stefanie W. Benoit, Jens Vikse, Brandon A. Berger, Christina Pulvino, Jonathan Hoehn, et al. (+4)
144 [GO] 2020―Nov―30 Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study Anna Schaffner, Lorenz Risch, Myriam Weber, Sarah Thiel, Katharina Jüngert, Michael Pichler, et al. (+8)
145 [GO] 2020―Nov―30 Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients Alberto Dolci, Cristina Robbiano, Elena Aloisio, Mariia Chibireva, Ludovica Serafini, Felicia Stefania Falvella, et al. (+2)
146 [GO] 2020―Nov―30 Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays Jason Wei Ming Tham, Shu Chi Ng, Chean Nee Chai, Siyu Png, Eunice Jia Min Tan, Li Jie Ng, et al. (+10)
147 [GO] 2020―Nov―30 Performance of three automated SARS-CoV-2 antibody assays and relevance of orthogonal testing algorithms Evelyne Huyghe, Hilde Jansens, Veerle Matheeussen, Ilse Hoffbauer, Herman Goossens, Bart Peeters
148 [GO] 2020―Nov―03 Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role Stelios F. Assimakopoulos, Andreas Emmanuil, Asimina Tsimeka, Theodora Chalkidi, Markos Marangos, Charalambos Gogos
149 [GO] 2020―Oct―24 Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests Federico Cabitza, Andrea Campagner, Davide Ferrari, Chiara Di Resta, Daniele Ceriotti, Eleonora Sabetta, et al. (+5)
150 [GO] 2020―Oct―24 Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection Eloísa Urrechaga, Urko Aguirre, Pablo Pedro España, Luis García de Guadiana
151 [GO] 2020―Oct―20 A biological profile for diagnosis and outcome of COVID-19 patients Mehdi Khourssaji, Virginie Chapelle, Anton Evenepoel, Leila Belkhir, Jean Cyr Yombi, Marie-Astrid van Dievoet, et al. (+7)
152 [GO] 2020―Oct―07 Editorial and executive summary: IFCC Interim Guidelines on clinical laboratory testing during the COVID-19 pandemic Giuseppe Lippi, Andrea Horvath, Khosrow Adeli
153 [GO] 2020―Oct―07 IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients Simon Thompson, Mary Kathryn Bohn, Nicasio Mancini, Tze Ping Loh, Cheng-Bin Wang, Matthias Grimmler, et al. (+18)
154 [GO] 2020―Oct―07 IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2 Mary Kathryn Bohn, Tze Ping Loh, Cheng-Bin Wang, Robert Mueller, David Koch, Sunil Sethi, et al. (+18)
155 [GO] 2020―Oct―07 IFCC interim guidelines on molecular testing of SARS-CoV-2 infection Mary Kathryn Bohn, Nicasio Mancini, Tze Ping Loh, Cheng-Bin Wang, Matthias Grimmler, Maurizio Gramegna, et al. (+17)
156 [GO] 2020―Oct―05 Can routine laboratory variables predict survival in COVID-19? An artificial neural network-based approach Alejandro Santos-Lozano, Fernando Calvo-Boyero, Ana López-Jiménez, Cecilia Cueto-Felgueroso, Adrián Castillo-García, Pedro L. Valenzuela, et al. (+4)
157 [GO] 2020―Sep―25 SARS-CoV-2 antibody performances: we need better criteria Claudio Galli, Mario Plebani
158 [GO] 2020―Sep―25 Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time? Giuseppe Lippi
159 [GO] 2020―Sep―07 Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study Rita Christiane Baron, Lorenz Risch, Myriam Weber, Sarah Thiel, Kirsten Grossmann, Nadia Wohlwend, et al. (+16)
160 [GO] 2020―Aug―28 SARS-CoV-2 serosurvey in health care workers of the Veneto Region Mario Plebani, Andrea Padoan, Ugo Fedeli, Elena Schievano, Elena Vecchiato, Giuseppe Lippi, et al. (+3)
161 [GO] 2020―Aug―26 Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only) Mauro Panteghini
162 [GO] 2020―Aug―18 Blood sampling after COVID-19 - How to organize large scale phlebotomy services in the post SARS CoV-2 era Niels de Jonge, Robert Herpers, Myriam Roelofs, Edmée van Dongen
163 [GO] 2020―Aug―18 Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China Chi Zhu, Siyuan Yu, Huangwei Zhao, Hui Shen, Ji Yang, Liming Zhao, Wenjuan Wu
164 [GO] 2020―Aug―18 Evaluation of three fully-automated SARS-CoV-2 antibody assays Sebastian Hörber, Jelena Soldo, Lasse Relker, Stefan Jürgens, Julia Guther, Silke Peter, et al. (+2)
165 [GO] 2020―Aug―18 Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer Andrea Padoan, Francesco Bonfante, Laura Sciacovelli, Chiara Cosma, Daniela Basso, Mario Plebani
166 [GO] 2020―Aug―18 Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays Chungen Qian, Mi Zhou, Fangming Cheng, Xiaotao Lin, Yijun Gong, Xiaobing Xie, et al. (+14)
167 [GO] 2020―Aug―18 Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States Giuseppe Lippi, Brandon Michael Henry, Jonathan Hoehn, Stefanie Benoit, Justin Benoit
168 [GO] 2020―Jul―22 Managing COVID-19 outbreak in Nigeria: matters arising Augustine Anayochukwu Onyeaghala, Isiramen Olajide
169 [GO] 2020―Jul―22 Serum prealbumin deserves more significance in the early triage of COVID-19 patients Xiao-long Guo, Yan Zhang, Yu-hua Zeng, Feng-ya Zhao, Wei-ping Liu, Li Xiao, et al. (+2)
170 [GO] 2020―Jul―22 Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization Elena Aloisio, Ludovica Serafini, Mariia Chibireva, Alberto Dolci, Mauro Panteghini
171 [GO] 2020―Jul―17 Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis Xiaoling Deng, Beibei Liu, Jiahuan Li, Junli Zhang, Yajuan Zhao, Keshu Xu
172 [GO] 2020―Jul―16 Laboratory work safety rules and guidelines during COVID-19 pandemic in Polish clinical laboratories - do our laboratories work according to a recent IFCC Taskforce Recommendations? Milena Małecka, Kinga Ogrodzińska, Gabriela Salczyńska, Olga Ciepiela
173 [GO] 2020―Jul―13 Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China Bingqi Wang, Min Hu, Yaping Ren, Xinyi Xu, Zeyou Wang, Xing Lyu, et al. (+7)
174 [GO] 2020―Jul―10 Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Giuseppe Lippi, Carl J. Lavie, Brandon M. Henry, Fabian Sanchis-Gomar
175 [GO] 2020―Jul―10 Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital Nicola Clementi, Roberto Ferrarese, Marco Tonelli, Virginia Amato, Sara Racca, Massimo Locatelli, et al. (+4)
176 [GO] 2020―Jul―10 Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study Julien Favresse, Christine Eucher, Marc Elsen, Kim Laffineur, Jean-Michel Dogné, Jonathan Douxfils
177 [GO] 2020―Jul―10 Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient Jean-Claude Alvarez, Pierre Moine, Isabelle Etting, Djillali Annane, Islam Amine Larabi
178 [GO] 2020―Jul―10 Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2 Mette C. Tollånes, Anne-Marte Bakken Kran, Eirik Abildsnes, Pål A. Jenum, Anne C. Breivik, Sverre Sandberg
179 [GO] 2020―Jul―10 Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2 Bram Decru, Jan Van Elslande, Matthias Weemaes, Els Houben, Ine Empsen, Emmanuel André, et al. (+3)
180 [GO] 2020―Jul―10 The early antibody response to SARS-Cov-2 infection Ruggero Dittadi, Haleh Afshar, Paolo Carraro
181 [GO] 2020―Jul―10 Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice Mario Plebani, Andrea Padoan, Laura Sciacovelli, Daniela Basso
182 [GO] 2020―Jul―10 Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing Steef Kurstjens, Armando van der Horst, Robert Herpers, Mick W. L. Geerits, Yvette C. M. Kluiters-de Hingh, Eva-Leonne Göttgens, et al. (+4)
183 [GO] 2020―Jun―23 SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics Daniela Basso, Ada Aita, Filippo Navaglia, Elisa Franchin, Paola Fioretto, Stefania Moz, et al. (+6)
184 [GO] 2020―Jun―09 Variability between testing methods for SARS-CoV-2 nucleic acid detection 16 days post-discharge: a case report Qiongying Hu, Xue Yang, Peiyang Gao, Jianyuan Tang, Qingxiao Liu, Qiurong Du, et al. (+5)
185 [GO] 2020―Jun―04 Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey Tze Ping Loh, Andrea Rita Horvath, Cheng-Bin Wang, David Koch, Giuseppe Lippi, Nicasio Mancini, et al. (+5)
186 [GO] 2020―Jun―04 Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey Tze Ping Loh, Andrea Rita Horvath, Cheng-Bin Wang, David Koch, Khosrow Adeli, Nicasio Mancini, et al. (+5)
187 [GO] 2020―Jun―02 Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19) Graziella Bonetti, Filippo Manelli, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Antonio Marino, et al. (+5)
188 [GO] 2020―Jun―02 Critical role of laboratory medicine in the global response to the COVID-19 pandemic Khosrow Adeli
189 [GO] 2020―May―28 Low levels of total and ionized calcium in blood of COVID-19 patients Fabrizio Cappellini, Rinaldo Brivio, Marco Casati, Annalisa Cavallero, Ernesto Contro, Paolo Brambilla
190 [GO] 2020―May―28 Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence Mary Kathryn Bohn, Giuseppe Lippi, Andrea Horvath, Sunil Sethi, David Koch, Maurizio Ferrari, et al. (+4)
191 [GO] 2020―May―28 Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department Luca Bernasconi, Michael Oberle, Valentin Gisler, Cornelia Ottiger, Hans Fankhauser, Philipp Schuetz, et al. (+2)
192 [GO] 2020―May―26 ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19 Joris R. Delanghe, Marijn M. Speeckaert, Marc L. De Buyzere
193 [GO] 2020―May―26 Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis Ivana Lapić, Dunja Rogić, Mario Plebani
194 [GO] 2020―May―26 Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations Giuseppe Lippi, Khosrow Adeli, Maurizio Ferrari, Andrea R. Horvath, David Koch, Sunil Sethi, Cheng-Bin Wang
195 [GO] 2020―May―26 No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection Mostafa Saadat
196 [GO] 2020―May―26 Antibody tests for COVID-19: drawing attention to the importance of analytical specificity Phedias Diamandis, Ioannis Prassas, Eleftherios P. Diamandis
197 [GO] 2020―May―26 Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation Emmanuel J. Favaloro, Jecko Thachil
198 [GO] 2020―May―26 Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019 Xiurong Ding, Yanhua Yu, Bichao Lu, Jianbo Huo, Ming Chen, Yanfang Kang, et al. (+2)
199 [GO] 2020―May―26 Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody Marie Tré-Hardy, Alain Wilmet, Ingrid Beukinga, Jean-Michel Dogné, Jonathan Douxfils, Laurent Blairon
200 [GO] 2020―May―14 COVID-19: progression of disease and intravascular coagulation - present status and future perspectives Job Harenberg, Emmanuel Favaloro
201 [GO] 2020―May―11 The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene Ettore D. Capoluongo, Felice Amato, Giuseppe Castaldo
202 [GO] 2020―May―11 Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy Graziella Bonetti, Filippo Manelli, Andrea Patroni, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, et al. (+6)
203 [GO] 2020―May―11 The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study Yufen Zheng, Ying Zhang, Hongbo Chi, Shiyong Chen, Minfei Peng, Lifei Luo, et al. (+4)
204 [GO] 2020―Apr―17 Routine blood tests as a potential diagnostic tool for COVID-19 Davide Ferrari, Andrea Motta, Marta Strollo, Giuseppe Banfi, Massimo Locatelli
205 [GO] 2020―Apr―17 Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) Chenyao Lin, Jie Xiang, Mingzhe Yan, Hongze Li, Shuang Huang, Changxin Shen
206 [GO] 2020―Apr―17 Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation Peter A. Kavsak, Kerstin de Wit, Andrew Worster
207 [GO] 2020―Apr―17 Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Brandon Michael Henry, Maria Helena Santos de Oliveira, Stefanie Benoit, Mario Plebani, Giuseppe Lippi
208 [GO] 2020―Apr―17 COVID-19 infections are also affected by human ACE1 D/I polymorphism Joris R. Delanghe, Marijn M. Speeckaert, Marc L. De Buyzere
209 [GO] 2020―Apr―17 The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019 Rui Liu, Qingfeng Ma, Huan Han, Hanwen Su, Fang Liu, Kailang Wu, et al. (+2)
210 [GO] 2020―Apr―17 Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays Giuseppe Lippi, Gian Luca Salvagno, Manuela Pegoraro, Valentina Militello, Cecilia Caloi, Angelo Peretti, et al. (+4)
211 [GO] 2020―Apr―17 Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children Shupeng Jiang, Panpan Liu, Ge Xiong, Zhaohui Yang, Ming Wang, Yan Li, Xue-jie Yu
212 [GO] 2020―Apr―17 Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics Andrea Padoan, Chiara Cosma, Laura Sciacovelli, Diego Faggian, Mario Plebani
213 [GO] 2020―Apr―02 Laboratory diagnostics within a modular hospital at the time of Coronavirus disease 2019 (COVID-19) in Wuhan Liu Yusong, Peng Duanliang, Yang Jia, Chen Dunyan, Jia Hongbing, Yu Siyuan, et al. (+3)
214 [GO] 2020―Apr―02 One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients Francesca Tosato, Chiara Giraudo, Michela Pelloso, Giulia Musso, Elisa Piva, Mario Plebani
215 [GO] 2020―Apr―02 Clinical laboratory and SARS-CoV-2 infection: where do we stand? Claudio Galli, Mario Plebani
216 [GO] 2020―Apr―02 Decreased “WBC*LYM” was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan Chi Zhang, Linjing Zhang, Xing Chen, Hui Zhang, Yang Fei
217 [GO] 2020―Mar―19 The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks Giuseppe Lippi, Mario Plebani
218 [GO] 2020―Mar―15 Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) Giuseppe Lippi, Ana-Maria Simundic, Mario Plebani
219 [GO] 2020―Mar―15 Laboratory abnormalities in children with novel coronavirus disease 2019 Brandon Michael Henry, Giuseppe Lippi, Mario Plebani
220 [GO] 2020―Mar―15 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Huan Han, Lan Yang, Rui Liu, Fang Liu, Kai-lang Wu, Jie Li, et al. (+2)

220 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec